JUAN LABADIE: Open Payments
NPI 1770609984 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 9 payments from 7 companies in 2025. Trend: 2023 $163 · 2024 $136 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 1 | $111 |
| Alkermes, Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| MILLICENT US INC | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: Altis, INVEGA, INTRAROSA, ARISTADA, FANAPT, CAPLYTA, VIVITROL, VRAYLAR.
Industry payments across LA — which companies pay providers there.
